Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_assertion type Assertion NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_head.
- NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_assertion description "[Combined genetic and transcriptional analyses showed consistent overexpression of GATA-6 in all carcinomas with 18q11.2 gain, as well as in the majority of pancreatic cancers examined (17 of 30 cancers, 56.7%) that did not have gain of this region.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_provenance.
- NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_assertion evidence source_evidence_literature NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_provenance.
- NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_assertion SIO_000772 18769116 NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_provenance.
- NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_assertion wasDerivedFrom befree-20150227 NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_provenance.
- NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_assertion wasGeneratedBy ECO_0000203 NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_provenance.